<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201215</date><key>pmc.key</key><document><id>2749934</id><infon key="license">CC BY</infon><passage><infon key="alt-title">Rat Gene Profiling Changes</infon><infon key="article-id_doi">10.1371/journal.pone.0007271</infon><infon key="article-id_pmc">2749934</infon><infon key="article-id_pmid">19787071</infon><infon key="article-id_publisher-id">09-PONE-RA-08037R1</infon><infon key="elocation-id">e7271</infon><infon key="issue">9</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</infon><infon key="name_0">surname:Morris;given-names:Tiffany J.</infon><infon key="name_1">surname:Vickers;given-names:Mark</infon><infon key="name_2">surname:Gluckman;given-names:Peter</infon><infon key="name_3">surname:Gilmour;given-names:Stewart</infon><infon key="name_4">surname:Affara;given-names:Nabeel</infon><infon key="name_5">surname:Gaetani;given-names:Silvana</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">4</infon><infon key="year">2009</infon><offset>0</offset><text>Transcriptional Profiling of Rats Subjected to Gestational Undernourishment: Implications for the Developmental Variations in Metabolic Traits</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>143</offset><text>A link has been established between prenatal nutrition and the development of metabolic and cardiovascular diseases later in life, a process referred to as developmental programming. It has been suggested that the trajectory of development is shifted by alterations in the maternal nutritional state leading to changes in developmental plasticity, in part underpinned by epigenetic changes in gene regulation. However, to date, only candidate gene approaches have been used to assess expression and molecular changes in the offspring of maternally undernourished animals. Furthermore, most work has focused on animals at an age where the programmed phenotype is already manifest and little is known about changes in gene expression in the offspring prior to development of obesity and related metabolic disorders. Gene expression profiles of liver, retroperitoneal white adipose fat, and biceps femoris skeletal muscle tissue from young adult male rats (55 days old) in which nutritional status had been manipulated in utero by maternal undernutrition (UN) were compared to the profiles of offspring of ad libitum fed mothers serving as the control group (AD) (8 offspring/group). The expression profiles were determined using the Illumina RatRef-12 BeadChip. No significant changes in expression were identified for skeletal muscle or white adipose tissue. However, studies of liver tissue showed 249 differentially expressed genes (143 up regulated, 106 down regulated). Although the animals at day 55 have yet to develop obesity they already show biochemical abnormalities and by day 110 express a phenotype characterized by increased adiposity and altered insulin sensitivity. An analysis of pathways affected suggests that intrauterine programming of UN animals to favor fat as an energy source results in mitochondrial dysfunction which initially affects the postnatal hepatic function and subsequently, via the resultant metabolic changes in other organs leads to the evolution of a phenotype similar to that of the metabolic syndrome.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2186</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2199</offset><text>Developmental plasticity is the process by which environmental factors acting during critical windows in early life affect the developmental trajectory and thus the mature phenotype. Such changes are often irreversible and are generally considered to be underpinned at least in part by epigenetic processes. While adaptive in origin developmental plasticity can have maladaptive consequences and thus in humans can affect health.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2629</offset><text>The developing fetus is completely dependent on its mother and so it follows that maternal nutrition during pregnancy, in particular, has a strong influence on the intrauterine environment. The DOHaD (Developmental Origins of Health and Disease) hypothesis proposes that the metabolic syndrome (i.e. coronary heart disease, type 2 diabetes, stroke, hypertension) originates through developmental plasticity in response to undernutrition during fetal life and infancy. It has been hypothesized that these diseases of later life arise from a mismatch between the actual postnatal environment and that predicted by the fetus during the phase of developmental plasticity. A variety of maternal nutritional manipulations in the rat have induced offspring who develop obesity, insulin resistance, and endothelial dysfunction in later life including global maternal undernutrition as used in this study and maternal low protein by isocaloric diets.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3571</offset><text>The mechanistic basis of such changes is only now being explored. It has been proposed that epigenetic modifications of the fetal genome establish new patterns of gene expression that reset the metabolic state that is maintained into adulthood. Effects on candidate genes using such rat models have focused on genes known to be significant in the metabolic syndrome including peroxisomal proliferator-activated receptor (PPARÎ±) and the glucocorticoid receptor (GR). These observations suggest that there are methylation differences in the promoters of these genes and changes in mRNA levels between the offspring of normally and undernourished mothers. A broader picture of the cellular functions and genetic pathways that may be implicated can be obtained using a non-biased, global microarray approach to study gene expression in key tissues between offspring of control and undernourished mothers.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4476</offset><text>In the present study, an established rat model of balanced maternal undernutrition has been used for investigation of gene expression differences in target tissues (liver, retroperitoneal white adipose fat, and biceps femoris skeletal muscle) between offspring of control and undernourished mothers. We studied young adult rats at day 55 of age when they have not yet developed the abnormal phenotype in order to identify any gene expression changes that may play a role in predisposing these animals to the development of the metabolic syndrome. The findings show that no significant gene expression changes are detected between the two groups in skeletal muscle and white adipose tissue. However, the liver reveals 249 significant gene expression differences (p&lt;0.05) showing significant down regulation of expression of several key genes affecting the entry of glucose into the cell and its metabolism via the glycolytic and tricarboxylic acid pathways. This would result in a substantial impairment in their ability to utilize carbohydrate on restoration of a normal diet. In addition, there was a marked increase in expression of genes associated with the intracellular trafficking of fatty acids, their peroxisomal degradation and their entry into the mitochondrion to undergo Î²-oxidation. This might suggest that following intrauterine undernutrition these animals have lost the flexibility to switch between carbohydrate and fat as energy sources. The analysis also reveals a substantial impairment of the electron transport chain as evidenced by a down regulation in expression of 3 components of complex I and the ATP synthase that generates ATP from the proton gradient. There is also a deficit in expression of a key enzyme in the biosynthesis of the NAD proton carrier.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6262</offset><text>We suggest that maternal undernutrition leads to offspring that favor fat as an energy source thus resulting in mitochondrial dysfunction that initially affects postnatal hepatic function and subsequently, other organs.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6482</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6504</offset><text>Animals</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6512</offset><text>This study exploited a well defined model of developmental programming via maternal undernutrition. Briefly, virgin Wistar rats (age, 100Â±5 days) were time mated using a rat estrous cycle monitor to assess the stage of estrous of the animals before introducing the male. After confirmation of mating, rats were housed individually in standard rat cages with free access to water. All rats were kept in the same room with constant temperature maintained at 25Â°C and a 12-h light/12-h darkness cycle. Animals were assigned to one of two nutritional groups: a) undernutrition (30% of ad libitum) of a standard chow diet throughout gestation (UN group), b) standard chow diet ad libitum throughout gestation (AD group). Food intake and maternal weights were recorded daily until the end of pregnancy. After birth, pups were weighed and litter size was adjusted to 8 pups per litter to assure adequate and standardized nutrition until weaning. Pups from undernourished mothers were cross-fostered onto dams that had received AD feeding throughout pregnancy. At weaning (day 22), animals were weight matched within maternal dietary group to 2 animals per cage. Eight animals per group were culled at day 55 following an overnight fast to represent an age known to precede the development of increased adiposity and altered insulin sensitivity in UN offspring. Tissues (liver, retroperitoneal white adipose fat, and biceps femoris skeletal muscle) were immediately dissected and snap-frozen in liquid nitrogen for molecular analysis. A subcohort of animals (nâ=â8 per group) were maintained until postnatal day 110 to represent an age where phenotypic changes in growth and metabolism between AD and UN offspring have previously been reported. The Animal Ethics Committee of The University of Auckland approved all animal manipulations.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8348</offset><text>Phenotypic Measurements</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8372</offset><text>Serial dual-energy x-ray absorptiometry (DEXA) analysis was performed on the animals at day 55 and day 110 to establish body composition and assessment of bone parameters. In addition to DEXA, body adiposity was assessed via standard techniques (fat depot dissection and weighing) following post-mortem. Body weight and food and water intake were monitored. Plasma analysis incorporated IGF-1, insulin, C-peptide, and lipid profiles. Statistical analyses were performed with the Knowledge Discovery Environment (InforSense Ltd., London, UK) statistical package. Differences between groups were determined by a T-test for difference in variance with an FDR correction, and data are shown as an adjusted p-valueÂ±standard error.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9099</offset><text>Microarray Hybridization and Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9137</offset><text>Global gene expression analysis was performed using the Illumina Bead Array Platform. Briefly, total RNA was isolated from cells with TRIzol reagent (Invitrogen, Paisley, Scotland, UK) followed by column purification (RNeasy, Qiagen, UK). RNA quality was assessed with the Lab-on-a-chip system (Agilent, Palo Alto, CA). The RNA samples were amplified following the Illumina TotalPrep RNA amplification protocol. The fluorescent labeling and hybridization of RNA samples were also performed according to custom protocols defined in the manufacturer's instructions. The samples from liver, skeletal muscle, and white adipose fat tissue for male offspring (nâ=â8) were hybridized to the RatRef-12 BeadChip available from Illumina (sampling 21,290 genes from the rat transcriptome). The hybridization signals were captured and quantified using a Bead Array scanner and the associated Bead Studio software. Bead Studio includes a spectrum of internal controls for determining data quality. These check for consistency in signal intensity, expected background and noise levels, mismatches versus perfect matches, and signal in housekeeping genes (Figure S1A-S1H). Data was exported and normalization was performed in R (Bioconductor) using the Limma and Lumi Bioconductor packages for microarray analysis. Data was filtered for those showing expression on at least one array and a variance-stabilizing transformation was done to take advantage of the multiple technical replicates (on average 20â30 per array) for each gene available on each Illumina chip. Quantile normalization was chosen to remove technical variability between arrays. Density plots of intensity and box plots of amplitude were used to visualize the raw data compared to the filtered and normalized data (Figure S2A-S2D). Limma was used for pairwise comparisons between AD and UN using a linear model to compute p-values, which were adjusted using the Benjamini and Hochberg multiple testing correction. The derivation of the p-value reflects the degree of variance between biological replicates and thus is a measure of the confidence in assigning significance of small fold changes in gene expression. Genes with a p-value&lt;0.05 were considered to be significantly differentially expressed. Gene ontology analysis was done using DAVID: Database for Analysis, Visualization, Integrated Discovery and Ingenuity Pathway Analysis software (Ingenuity, Stanford USA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>11570</offset><text>Quantitative Real-Time PCR</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11597</offset><text>The comparative expression levels in AD and UN RNA of seven genes identified as differentially expressed from our microarray data were verified by qRT-PCR, together with the expression levels of five genes not present on the array. Cyclophilin was used for the generation of a standard curve and normalization of the RNA concentration. Each qRT-PCR was performed in triplicate. Real-time RT-PCR was performed in 96-well white plates (Abgene) using the Verso SYBR Green 2-Step qRT-PCR Fluorescein Kit (Thermo Scientific, UK) according to the manufacturer's protocols; the resulting fluorescence was quantified using an iCycler system (Bio-Rad). The threshold cycle value (CT) was obtained for each well as the cycle number at which the measured fluorescence crossed the arbitrary threshold of 150 units (all values are in log phase). The average CT was calculated for each gene in each sample. Data were normalized to cyclophilin, with ÎCT calculated as follows: ÎCT â=â CT(test)âCT(cyclophilin). ÎÎCT values were then calculated as the change in ÎCT for the UN sample relative to the ÎCT value for the AD sample using the equation: ÎÎCT â=â2CT(test)â2CT(cyclophilin). This data is plotted in Figure 1 and primer sequences are shown in Table S1.</text></passage><passage><infon key="file">pone.0007271.g001.jpg</infon><infon key="id">pone-0007271-g001</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>12874</offset><text>qRT-PCR for Microarray Verification.</text></passage><passage><infon key="file">pone.0007271.g001.jpg</infon><infon key="id">pone-0007271-g001</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>12911</offset><text>QRT-PCR for the two treatments was run in triplicate with cyclophilin as a control. The ÎÎCT values are shown for each gene along with error bars for standard error. (A) Seven genes were chosen from the 249 significantly differentially expressed genes on the Illumina microarray. The RNA from the 8 biological replicates was pooled for each of the two treatment groups. In Table 2, the ÎÎCT values have been converted into a fold change for comparison to the array results. (B) Five Previously Published Candidate Genes from Lillycrop et al. were analyzed be qRT-PCR. Each of the eight individual samples was run in triplicate (24 data points for each treatment group). Due to the large number of data points, the error bars are very small and difficult to see.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>13689</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13697</offset><text>Phenotypic Assessment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13719</offset><text>For each of the 8 animals in each of the AD and UN groups, a series of phenotypic measurements relevant to the metabolic syndrome was recorded at day 55 (Table 1), the age at which gene expression analysis was performed, and in a subcohort of animals at day 110 (Table 2). From these measurements, it is clear that at day 55 there are very few differences in key indicators (insulin resistance, glucose intolerance, elevated blood lipids and increased adiposity) as might be expected at this early stage in the progression of the metabolic syndrome. However, by day 110 there are clear indications of abnormalities in insulin sensitivity and markers of adiposity including total fat mass and plasma leptin concentrations.</text></passage><passage><infon key="file">pone-0007271-t001.xml</infon><infon key="id">pone-0007271-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>14441</offset><text>Phenotype data, day 55 offspring.</text></passage><passage><infon key="file">pone-0007271-t001.xml</infon><infon key="id">pone-0007271-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AD mean&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;UN mean&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Adjusted p-value&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Body weight (grams)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;282.38&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;234.50&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Body length (mm)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;203.63&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;192.63&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.005&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liver weight (% body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.65&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.02&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.014&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Spleen weight (% body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.32&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.27&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Heart weight (% body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.36&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.71&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fat pad weight (% of body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.80&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.59&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.039&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Plasma glucose (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.24&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.67&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Urea (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.76&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.010&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Free Fatty Acids (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.79&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.68&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glycerol (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total Protein (g/DL)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.45&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.39&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lipase (U/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.10&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.06&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C-Peptide (pg/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;132.18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;162.85&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Triglycerides (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.78&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.77&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IGF-1 (ng/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1221.50&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1277.63&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Creatinine (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23.64&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Insulin (ng/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.33&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.53&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total Fat (%)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24.09&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23.66&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LDL (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.27&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.46&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.006&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HDL (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.27&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.34&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LDLâ¶HDL ratio&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.35&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.003&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>14475</offset><text>	AD mean	UN mean	Adjusted p-value	 	Body weight (grams)	282.38	234.50	0.001	 	Body length (mm)	203.63	192.63	0.005	 	Liver weight (% body weight)	3.65	3.02	0.014	 	Spleen weight (% body weight)	0.32	0.27	NS	 	Heart weight (% body weight)	0.36	0.71	NS	 	Fat pad weight (% of body weight)	0.80	0.59	0.039	 	Plasma glucose (mmol/l)	6.24	6.67	NS	 	Urea (mmol/l)	4.76	6.18	0.010	 	Free Fatty Acids (mmol/l)	0.79	0.68	NS	 	Glycerol (mmol/l)	0.21	0.19	NS	 	Total Protein (g/DL)	5.45	5.39	NS	 	Lipase (U/l)	9.10	9.06	NS	 	C-Peptide (pg/ml)	132.18	162.85	NS	 	Triglycerides (mmol/l)	0.78	0.77	NS	 	IGF-1 (ng/ml)	1221.50	1277.63	NS	 	Creatinine (mmol/l)	20.15	23.64	NS	 	Insulin (ng/ml)	0.33	0.53	NS	 	Total Fat (%)	24.09	23.66	NS	 	LDL (mmol/l)	0.27	0.46	0.006	 	HDL (mmol/l)	1.27	1.34	NS	 	LDLâ¶HDL ratio	0.21	0.35	0.003	 	</text></passage><passage><infon key="file">pone-0007271-t001.xml</infon><infon key="id">pone-0007271-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>15292</offset><text>Phenotypic measurements relevant to metabolic syndrome measured for each of the eight animals in each treatment group at day 55. The p-value was calculated with a t-test and an FDR correction. NS â=â not significant.</text></passage><passage><infon key="file">pone-0007271-t002.xml</infon><infon key="id">pone-0007271-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>15513</offset><text>Phenotype data, day 110 male offspring.</text></passage><passage><infon key="file">pone-0007271-t002.xml</infon><infon key="id">pone-0007271-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AD mean&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;UN mean&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Adjusted p-value&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Body weight (grams)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;511&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;489&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Body length (mm)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;238&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;218&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total Fat (%)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27.8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;35.6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fat pad weight (% of body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.45&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leptin (ng/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.005&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Insulin (ng/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.260&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.502&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C-Peptide (pg/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;466&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;729&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.05&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Plasma glucose (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.0&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Free Fatty Acids (mmol/l)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.86&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.99&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liver weight (% body weight)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.92&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.78&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IGF-1 (ng/ml)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1236&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1145&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NS&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>15553</offset><text>	AD mean	UN mean	Adjusted p-value	 	Body weight (grams)	511	489	NS	 	Body length (mm)	238	218	0.05	 	Total Fat (%)	27.8	35.6	0.05	 	Fat pad weight (% of body weight)	1.45	2.14	0.05	 	Leptin (ng/ml)	9.6	22.5	0.005	 	Insulin (ng/ml)	0.260	0.502	0.001	 	C-Peptide (pg/ml)	466	729	0.05	 	Plasma glucose (mmol/l)	7.0	7.2	NS	 	Free Fatty Acids (mmol/l)	0.86	0.99	NS	 	Liver weight (% body weight)	2.92	2.78	NS	 	IGF-1 (ng/ml)	1236	1145	NS	 	</text></passage><passage><infon key="file">pone-0007271-t002.xml</infon><infon key="id">pone-0007271-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>15989</offset><text>Phenotypic measurements relevant to metabolic syndrome measured for each of the eight animals in each treatment group at day 110. The p-value was calculated with a t-test and an FDR correction. NS â=â not significant.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16211</offset><text>Expression Analysis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16231</offset><text>Expression profiling was done for liver, white adipose fat, and skeletal muscle tissue from young adult (55-day-old) male rats born to either AD or UN dams. In each group there were eight biological replicates, all of which were raised postnatally on an ad libitum diet. Expression profiles were determined using the Illumina RatRef-12 BeadChip that permits interrogation of 21,290 rat genes. Genes with a p-value&lt;0.05 were considered to show significant differential expression between the two groups. Using these criteria, no significant gene expression changes between the two groups were identified for skeletal muscle or white adipose tissue in the day 55 animals. However, the comparison for liver revealed a list of 249 differentially expressed genes. Table S2 summarizes the expression values for all genes represented on the array and Table S3 the list of 249 differentially expressed genes with associated p-values and fold changes between the two groups.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>17197</offset><text>Quantitative RT-PCR (qRT-PCR) Analysis of Selected Genes</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17254</offset><text>In order to confirm the expression data derived from array analysis, seven genes (IGFBP2 (NM_013122), FABP7 (NM_030832), Zfand2a (NM_001008363), DGAT2 (XM_574498), GYS2 (NM_013089), ADRA1B (NM_016991), and RBP1 (XM_230637)) found to be differentially expressed were selected for qRT-PCR on the pooled RNA samples for the biological replicates in each treatment group. Cyclophilin was used as an invariant control for normalization. Figure 1A summarizes the data and illustrates that the differences in ÎÎCt values between the AD and UN RNA populations for each gene are consistent with the expression changes determined by array analysis. These values were then converted to fold change to directly compare the qRT-PCR values to the expression values from the microarray (Table 3).</text></passage><passage><infon key="file">pone-0007271-t003.xml</infon><infon key="id">pone-0007271-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>18044</offset><text>Fold Change Values Comparing Microarray and QRT-PCR.</text></passage><passage><infon key="file">pone-0007271-t003.xml</infon><infon key="id">pone-0007271-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gene Symbol&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genbank Accession Number&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Microarray Expression (Fold Change)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;QRT-PCR Expression (Fold Change)&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ADRA1B&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NM_016991.2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.735&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.932&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DGAT2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;XM_574498.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.764&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.494&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FABP7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NM_030832.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.381&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.682&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GYS2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NM_013089.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.541&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.606&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IGFBP2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NM_013122.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.144&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.732&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Zfand2a&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NM_001008363.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.492&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.549&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;RPB1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;XM_230637.3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.631&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.217&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>18097</offset><text>Gene Symbol	Genbank Accession Number	Microarray Expression (Fold Change)	QRT-PCR Expression (Fold Change)	 	ADRA1B	NM_016991.2	0.735	1.932	 	DGAT2	XM_574498.1	0.764	0.494	 	FABP7	NM_030832.1	1.381	1.682	 	GYS2	NM_013089.1	1.541	1.606	 	IGFBP2	NM_013122.1	2.144	2.732	 	Zfand2a	NM_001008363.1	1.492	2.549	 	RPB1	XM_230637.3	1.631	1.217	 	</text></passage><passage><infon key="file">pone-0007271-t003.xml</infon><infon key="id">pone-0007271-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>18435</offset><text>Fold change for the QRT-PCR data and the Illumina expression data is compared for each of the seven genes from the Illumina arrays that were analyzed by QRT-PCR. Fold changes for the RT-PCR reflect directly the ÎÎCt values between the two groups after normalization.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18710</offset><text>Previous analysis has provided evidence that the expression of the PPARÎ±, GR and AOX (acyl-CoA oxidase) genes is altered in the liver of offspring from normally nourished mothers compared to mothers who had either a low protein diet or balanced undernutrition during pregnancy. It has also been suggested that PEPCK (phosphoenolpyruvate carboxykinase) and 11Î²-HSD2 (11Î²-hydroxysteroid dehydrogenase type 2) may also be genes influenced by diet. As these genes were not represented by any of the oligonucleotides on the RatRef-12 array, they were assessed by qRT-PCR in the AD and UN RNA populations using cyclophilin as the normalization control. The findings are shown in figure 1B for the 8 biological replicates in each treatment group. For PPARÎ± and PEPCK, there is no evidence for any differences in expression levels between the two treatment groups. However, GR, AOX and 11Î²-HSD2 show between 1.5 to 2-fold increases in expression in the UN treatment group.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>19692</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19703</offset><text>Animals at postnatal day 55 were chosen for gene expression analysis because they had completed puberty but had not begun to exhibit the features of the metabolic syndrome phenotype as observed later in adulthood and, as shown in the present study, as early as day 110 postnatally. Our results presented show that while there are differences in gene expression in hepatic tissue in day 55 males, there are no observed differences in white adipose fat or skeletal muscle. This is an intriguing finding, as both fat and skeletal muscle is adversely affected in the adult. This suggests that there is a cascade of biological processes that amplifies over time to lead to the phenotypic abnormalities. Previously Ozanne et al.  has shown, in a different but related experimental model of maternal low protein intake, that the expression of a limited number of genes in skeletal muscle is minimal early in life and accumulates later in life. It would appear that major changes in gene expression in the liver precede those in other metabolically relevant tissues.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20762</offset><text>The data for all three tissues is derived from 8 biological replicates in each treatment group with technical replication on each array varying from 20â30 fold. This means that for each gene represented on the array, there are between 160 and 240 measurements of expression level. This permits an accurate estimate of the variance that is used to derive the final p-value and provides confidence in the detection of small gene expression changes. Thus the changes found in liver are based on many measurements and are highly significant. This is further underscored by the absence of any significant changes in gene expression between the two groups in skeletal muscle or white adipose fat tissue subjected to the same analysis. The qRT-PCR analysis of candidate genes (PPARÎ± and PEPCK) showed very little difference in expression levels between the two groups in the day 55 male offspring. This contrasts with the 10-fold, 3-fold and 3-fold increase for PPARÎ±, GR and AOX, respectively, in the day 34 offspring born to nutritionally restricted mothers as reported by Lillycrop et al. . Four factors may explain this difference. First, the restricted diet is different (50% protein restriction only) whereas the diet in the study reported here is 30% of normal chow for all nutrients and may impact differently on gene expression. Second, in the Lillycrop et al. study the animals were weaned on day 28 and spent only 6 days in the post-weaning period compared to 33 days in this present study. Third, the composition of the post-weaning diet in the present study is grain-based as opposed to a purified diet containing 50% sucrose in the Lillycrop et al. study. Finally, the male and female tissues were pooled in the Lillycrop et al. study and there may be gender differences we have not explored. Similar to previous reports, GR, 11Î²-HSD2 and AOX show increases of between 1.5 to 2-fold in the offspring of undernourished mothers used in this study.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22726</offset><text>Analysis of the gene categories and associated pathways associated with differentially expressed genes (Table S3) has revealed some relevant changes that potentially impact on the metabolic phenotype. Table 4 summarizes the relevant categories to emerge from analysis of gene functions (some of which emerged from DAVID and Ingenuity analyses) associated with the list of differentially expressed genes. Figure 2A and 2B summarize the interrelationships between pathways involved in glucose, fat, and energy metabolism and highlight differentially regulated genes that influence these pathways.</text></passage><passage><infon key="file">pone.0007271.g002.jpg</infon><infon key="id">pone-0007271-g002</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>23321</offset><text>Genes that Influence Glucose, Fat, and Energy Metabolism Pathways and IGF-1 and PI3K Signaling Pathways.</text></passage><passage><infon key="file">pone.0007271.g002.jpg</infon><infon key="id">pone-0007271-g002</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>23426</offset><text>(A) Summarizes the interrelationships between pathways involved in glucose, fat, and energy metabolism and highlights differentially regulated genes that influence these pathways. (B) A summary of the genes that are altered in signaling through the IGF-1 and PI3K signaling pathways and their relevance to glucose and fat metabolism. Normal arrows indicate no change in gene expression; dashed arrows indicate down regulation; bold arrows indicate up-regulation.</text></passage><passage><infon key="file">pone-0007271-t004.xml</infon><infon key="id">pone-0007271-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>23889</offset><text>Analysis of gene function associated with differentially expressed genes.</text></passage><passage><infon key="file">pone-0007271-t004.xml</infon><infon key="id">pone-0007271-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;METABOLIC AREA&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SYMBOL&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GENE IDENTIFICATION&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;% ÎEXP&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FUNCTION&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Carbohydrate and Glucose metabolism&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gys2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;glycogen synthase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;stimulation of glucose storage&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gbe1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;glucan 1,4Î± branching enzyme&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â38&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;impairment of glycogen storage&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pgm1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;phosphoglucomutase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;increases glycogenesis over glycolysis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tpi&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;triose phosphate isomerase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â28&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;attenuation of glycolysis and energy production&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gcgr&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;glucagon receptor&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;attenuation of glycogenolysis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Trib3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tribbles homolog 3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;impairment of insulin/IGF signaling at Akt &lt;xref rid=&quot;pone.0007271-Du2&quot; ref-type=&quot;bibr&quot;&gt;[46]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ptprb&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;protein tyrosine phosphatase receptor type B&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;impairment of insulin/IGF signaling at Atk &lt;xref rid=&quot;pone.0007271-Haj1&quot; ref-type=&quot;bibr&quot;&gt;[47]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rbp1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Retinol binding protein 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;63&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;impairment of insulin/IGF signalling at PI3Kinase &lt;xref rid=&quot;pone.0007271-Farias1&quot; ref-type=&quot;bibr&quot;&gt;[30]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Igfbp2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;insulin-like growth factor binding protein 2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;114&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;impaired IGD binding to receptor&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p49/STRAP&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SRF-dependent transcription regulation associated protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;interference with GLUT4 biosynthesis and recycling &lt;xref rid=&quot;pone.0007271-Lisinski1&quot; ref-type=&quot;bibr&quot;&gt;[48]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TRIP3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;thyroid hormone interactor protein 3 (TRIP3)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;activator of NHF-4Î± dependent effects on glucose metabolism &lt;xref rid=&quot;pone.0007271-Iwahashi1&quot; ref-type=&quot;bibr&quot;&gt;[49]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dhtkd1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;dehydrogenase E1 and transketolase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;30&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;catalyses Î±ketoglutarateâsuccinylCoA in TCA&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fat and Lipid Metabolism&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crat&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;carnitine acyltransferase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;increased transport of acylCoA from cytosol to mitochondrion&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tmhle&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;trimethyllysine hydroxylase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;biosynthesis of carnitine&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dgat2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;diacylglycerol acyltransferase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;decreased synthesis of triglycerides&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fabp7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;fatty acid binding protein 7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;increased uptake and intracellular transport of fatty acids&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Scap&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SREBP cleavage activating protein (Scap)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;increased hepatic lipid synthesis &lt;xref rid=&quot;pone.0007271-Matsuda1&quot; ref-type=&quot;bibr&quot;&gt;[50]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Igfbp2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IGF binding protein 2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;114&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;protection against obesity and insulin resistance &lt;xref rid=&quot;pone.0007271-Wheatcroft1&quot; ref-type=&quot;bibr&quot;&gt;[51]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ptprb&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;protein tyrosine phosphatase receptor type B&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;contributes to hepatic leptin resistance &lt;xref rid=&quot;pone.0007271-Lam1&quot; ref-type=&quot;bibr&quot;&gt;[52]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Stard5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;steroidogenic acute regulatory protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;intracellular cholesterol transport&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cyp4f4&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cytochrome P450&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â28&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in cholesterol, steroid and leukotriene synthesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cyp4f6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cytochrome P450&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in cholesterol, steroid and leukotriene synthesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Atp8b1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ATPase class II type 8B&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;phosphatidyl serine and threonine transferase&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cidea&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cell death inducing DNA fragmentation factor Î±-like effector&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â28&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;shown to regulate energy expenditure and lipolysis &lt;xref rid=&quot;pone.0007271-Gummesson1&quot; ref-type=&quot;bibr&quot;&gt;[53]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Dahlman1&quot; ref-type=&quot;bibr&quot;&gt;[54]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Zhou1&quot; ref-type=&quot;bibr&quot;&gt;[55]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Bibikova1&quot; ref-type=&quot;bibr&quot;&gt;[56]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ebp&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;phenyalkylamine Ca2+ antagonist (emopamil) binding protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;isomerase involved in the conversion of lanosterol to cholesterol&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Amino Acid Metabolism&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Got2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;glutamate/oxaloacetate transaminase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â10&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;aspartate aminotransferase in aa catabolism and malate shuttle&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dhtkd1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;dehydrogenaseE1 and transketolase domain containing 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â30&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2-ketoglutarate dehydrogenase activity&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hpd&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4-hydroxyphenylpyruvate oxidase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;participates in tyrosine catabolism&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Haao&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3-hydroxyanthanillate dioxygenase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;participates in tryptophan catabolism&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Protein turnover&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Zfand2a&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;arsenite inducible RNA associated protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;adapts proteosome to counteract stress-induced proteotoxicity &lt;xref rid=&quot;pone.0007271-Stanhill1&quot; ref-type=&quot;bibr&quot;&gt;[57]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tmprss6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;transmembrane serine protease 6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Capn7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;calpain 7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cpn2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;carboxypeptidase N83&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â58&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Capsn1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;calpain small subunit 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fam108b1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cgi67 serine protease&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â2.8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Serpinb6b&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;serine(or cysteine) peptidase inhibitor,clade B, member 6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cand1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cullin associated/neddylation dissociated 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in targeted protein proteosomal degradation &lt;xref rid=&quot;pone.0007271-Min1&quot; ref-type=&quot;bibr&quot;&gt;[58]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dcun1d5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;defective in cullin neddylation1, domain 5 (DCN1)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in targeted protein proteosomal degradation &lt;xref rid=&quot;pone.0007271-Kurz1&quot; ref-type=&quot;bibr&quot;&gt;[59]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Txndc12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Thioredoxin domain containing 12 (Txndc12)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;protein refolding, defense against oxidative stress&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ubfd1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ubiquitin family domain containing 1 (Ubfd1)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in targeted protein proteosomal degradation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Eif4a1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;translation initiation factor 4A1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ribosomes&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl7a&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L7a (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rps19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein S19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L14 (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rps26&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein S26 (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rp23a&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein 23a (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl27a&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein 27a (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal proetin L21(mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl31&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L31&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl39&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L39&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rps17&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein S17 (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl24&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protetin L24&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rpl13&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein L13 (mitochondrial)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NPG1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;autoantigen NPG1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;required for the maturation/nuclear export of pre-ribosomes&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bxdc1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;brix domain containing 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;control of ribosome biogenesis &lt;xref rid=&quot;pone.0007271-Eisenhaber1&quot; ref-type=&quot;bibr&quot;&gt;[60]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crlz1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;charged amino acid leucine zipper 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;required for 18s rRNA processing&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rrp15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ribosomal protein processing homolog 15 (Rrp15)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cebpz&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CCAAT/enhancer binding protein zeta&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17.4&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ribosomal RNA processing &lt;xref rid=&quot;pone.0007271-Milkereit1&quot; ref-type=&quot;bibr&quot;&gt;[35]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Apoptosis&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dnase1l3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DNAse 1-like 3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;fragments DNA during apoptosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ppid&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;peptidyl prolyl isomerase D (Cyclophilin D)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;anti-apoptotic. Blocks mitochondrial permeability&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ei24&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;etoposide induced 2.4 mRNA&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;may suppress cell growth by inducing apoptosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Prkch&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;protein kinase C eta&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;anti-apoptotic. Potent activator of Raf1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sgpl1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;sphingosine phosphate lyase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;apoptotic. Enhances stress-induced ceramide release &lt;xref rid=&quot;pone.0007271-Reiss1&quot; ref-type=&quot;bibr&quot;&gt;[61]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Aatf&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;apoptosis antagonising factor&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;anti-apoptotic nuclear phosphoprotein transcription factor&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cidea&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cell death inducing DNA fragmentation factor Î±-like effector&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â28&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;apoptotic factor which induces DNA fragmentation &lt;xref rid=&quot;pone.0007271-Gummesson1&quot; ref-type=&quot;bibr&quot;&gt;[53]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Dahlman1&quot; ref-type=&quot;bibr&quot;&gt;[54]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Zhou1&quot; ref-type=&quot;bibr&quot;&gt;[55]&lt;/xref&gt;&lt;xref rid=&quot;pone.0007271-Bibikova1&quot; ref-type=&quot;bibr&quot;&gt;[56]&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SP16&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;serpin 9b protease inhibitor&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;regulates apoptosis by inhibiting caspases 8 and 10&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mitochondrion and Electron Transport Chain&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LOC499612&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NADH dehydrogenase (ubiquinone) complex unknown&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â11&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;uncharacterised component of electron transport chain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ndufc2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NADH dehydrogenase (ubiquinone) 1 complex unknown 2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;uncharacterised component of electron transport chain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ndufc6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NADH dehydrogenase (ubiquinone) 1 beta subcomplex 6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â16&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;component of Complex I of electron transport chain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ndufa8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â19&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;component of Complex I of electron transport chain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;p45/STRAP&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SRF-dependent transcription regulated associated factor&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â10&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;reported to interfere with Comlpex I assembly&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BC088177 - Qprt&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;quinolate phosphoribosyl transferase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â29&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;participates in NAD biosynthesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Qprt&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;quinolate phosphoribosyl transferase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;participates in NAD biosynthesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Atp5o&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ATP synthase H ion transporting&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of the mitochondrial ATP synthesis complex&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Atpi&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ATPase inhibitor&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;prevents ATP hydrolysis during electron flux&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ppid&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;peptidyl prolyl isomerase D (Cyclophilin)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â20&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of mitochondrial transition pore&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tim14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;translocase complex subunit Tim14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â29&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;component of the mitochondrial protein import motor&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Haao&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3-hydroxyanthanillate dioxygenase&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;provides quinolate for NAD synthesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Transcription&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crem&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;cAMP responsive element modulator&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PKA activation. Role in glucose and fat metabolism&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gtf2a2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;general transcription factor IIa 2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of the preinitiation transcription complex&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gtf2hI&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;general transcription factor II H, polypeptide 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of the preinitiation transcription complex&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MED21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mediator complex subunit 21&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of the RNA polymerase II transcription unit&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MED6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mediator complex subunit 6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;part of the RNA polymerase II transcription unit&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rbp1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;retinoic acid binding protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;63&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;RXR formation and PPAR activation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DDX52&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DEAD box polypeptide 52&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18.7&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ATP-dependent RNA helicase&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ccdc12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ccdc coiled-coil domain containing 12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;involved in mRNA splicing&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>23963</offset><text>METABOLIC AREA	SYMBOL	GENE IDENTIFICATION	% ÎEXP	FUNCTION	 	Carbohydrate and Glucose metabolism	Gys2	glycogen synthase	54	stimulation of glucose storage	 		Gbe1	glucan 1,4Î± branching enzyme	â38	impairment of glycogen storage	 		Pgm1	phosphoglucomutase	â14	increases glycogenesis over glycolysis	 		Tpi	triose phosphate isomerase	â28	attenuation of glycolysis and energy production	 		Gcgr	glucagon receptor	â15	attenuation of glycogenolysis	 		Trib3	Tribbles homolog 3	11	impairment of insulin/IGF signaling at Akt 	 		Ptprb	protein tyrosine phosphatase receptor type B	25	impairment of insulin/IGF signaling at Atk 	 		Rbp1	Retinol binding protein 1	63	impairment of insulin/IGF signalling at PI3Kinase 	 		Igfbp2	insulin-like growth factor binding protein 2	114	impaired IGD binding to receptor	 		p49/STRAP	SRF-dependent transcription regulation associated protein	10	interference with GLUT4 biosynthesis and recycling 	 		TRIP3	thyroid hormone interactor protein 3 (TRIP3)	6	activator of NHF-4Î± dependent effects on glucose metabolism 	 		Dhtkd1	dehydrogenase E1 and transketolase	30	catalyses Î±ketoglutarateâsuccinylCoA in TCA	 	Fat and Lipid Metabolism	Crat	carnitine acyltransferase	18	increased transport of acylCoA from cytosol to mitochondrion	 		Tmhle	trimethyllysine hydroxylase	â12	biosynthesis of carnitine	 		Dgat2	diacylglycerol acyltransferase	â12	decreased synthesis of triglycerides	 		Fabp7	fatty acid binding protein 7	40	increased uptake and intracellular transport of fatty acids	 		Scap	SREBP cleavage activating protein (Scap)	20	increased hepatic lipid synthesis 	 		Igfbp2	IGF binding protein 2	114	protection against obesity and insulin resistance 	 		Ptprb	protein tyrosine phosphatase receptor type B	25	contributes to hepatic leptin resistance 	 		Stard5	steroidogenic acute regulatory protein	â12	intracellular cholesterol transport	 		Cyp4f4	cytochrome P450	â28	involved in cholesterol, steroid and leukotriene synthesis	 		Cyp4f6	cytochrome P450	â18	involved in cholesterol, steroid and leukotriene synthesis	 		Atp8b1	ATPase class II type 8B	16.5	phosphatidyl serine and threonine transferase	 		Cidea	cell death inducing DNA fragmentation factor Î±-like effector	â28	shown to regulate energy expenditure and lipolysis 	 		Ebp	phenyalkylamine Ca2+ antagonist (emopamil) binding protein	20	isomerase involved in the conversion of lanosterol to cholesterol	 	Amino Acid Metabolism	Got2	glutamate/oxaloacetate transaminase	â10	aspartate aminotransferase in aa catabolism and malate shuttle	 		Dhtkd1	dehydrogenaseE1 and transketolase domain containing 1	â30	2-ketoglutarate dehydrogenase activity	 		Hpd	4-hydroxyphenylpyruvate oxidase	16	participates in tyrosine catabolism	 		Haao	3-hydroxyanthanillate dioxygenase	â12	participates in tryptophan catabolism	 	Protein turnover	Zfand2a	arsenite inducible RNA associated protein	40	adapts proteosome to counteract stress-induced proteotoxicity 	 		Tmprss6	transmembrane serine protease 6	â15		 		Capn7	calpain 7	â15		 		Cpn2	carboxypeptidase N83	â58		 		Capsn1	calpain small subunit 1	â21		 		Fam108b1	Cgi67 serine protease	â2.8		 		Serpinb6b	serine(or cysteine) peptidase inhibitor,clade B, member 6	25		 		Cand1	cullin associated/neddylation dissociated 1	15	involved in targeted protein proteosomal degradation 	 		Dcun1d5	defective in cullin neddylation1, domain 5 (DCN1)	13	involved in targeted protein proteosomal degradation 	 		Txndc12	Thioredoxin domain containing 12 (Txndc12)	20.6	protein refolding, defense against oxidative stress	 		Ubfd1	ubiquitin family domain containing 1 (Ubfd1)	14	involved in targeted protein proteosomal degradation	 		Eif4a1	translation initiation factor 4A1	20		 	Ribosomes	Rpl7a	ribosomal protein L7a (mitochondrial)	24		 		Rps19	ribosomal protein S19	22		 		Rpl14	ribosomal protein L14 (mitochondrial)	20		 		Rps26	ribosomal protein S26 (mitochondrial)	19		 		Rp23a	ribosomal protein 23a (mitochondrial)	19		 		Rpl27a	ribosomal protein 27a (mitochondrial)	18		 		Rpl21	ribosomal proetin L21(mitochondrial)	17		 		Rpl31	ribosomal protein L31	17		 		Rpl39	ribosomal protein L39	15		 		Rpl6	ribosomal protein L6	14		 		Rps17	ribosomal protein S17 (mitochondrial)	14		 		Rpl24	ribosomal protetin L24	14		 		Rpl13	ribosomal protein L13 (mitochondrial)	7		 		NPG1	autoantigen NPG1	16	required for the maturation/nuclear export of pre-ribosomes	 		Bxdc1	brix domain containing 1	11	control of ribosome biogenesis 	 		Crlz1	charged amino acid leucine zipper 1	26	required for 18s rRNA processing	 		Rrp15	ribosomal protein processing homolog 15 (Rrp15)	17		 		Cebpz	CCAAT/enhancer binding protein zeta	17.4	Ribosomal RNA processing 	 	Apoptosis	Dnase1l3	DNAse 1-like 3	40	fragments DNA during apoptosis	 		Ppid	peptidyl prolyl isomerase D (Cyclophilin D)	20	anti-apoptotic. Blocks mitochondrial permeability	 		Ei24	etoposide induced 2.4 mRNA	17	may suppress cell growth by inducing apoptosis	 		Prkch	protein kinase C eta	14	anti-apoptotic. Potent activator of Raf1	 		Sgpl1	sphingosine phosphate lyase	18	apoptotic. Enhances stress-induced ceramide release 	 		Aatf	apoptosis antagonising factor	13	anti-apoptotic nuclear phosphoprotein transcription factor	 		Cidea	cell death inducing DNA fragmentation factor Î±-like effector	â28	apoptotic factor which induces DNA fragmentation 	 		SP16	serpin 9b protease inhibitor	27	regulates apoptosis by inhibiting caspases 8 and 10	 	Mitochondrion and Electron Transport Chain	LOC499612	NADH dehydrogenase (ubiquinone) complex unknown	â11	uncharacterised component of electron transport chain	 		Ndufc2	NADH dehydrogenase (ubiquinone) 1 complex unknown 2	â12	uncharacterised component of electron transport chain	 		Ndufc6	NADH dehydrogenase (ubiquinone) 1 beta subcomplex 6	â16	component of Complex I of electron transport chain	 		Ndufa8	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 8	â19	component of Complex I of electron transport chain	 		p45/STRAP	SRF-dependent transcription regulated associated factor	â10	reported to interfere with Comlpex I assembly	 		BC088177 - Qprt	quinolate phosphoribosyl transferase	â29	participates in NAD biosynthesis	 		Qprt	quinolate phosphoribosyl transferase	â15	participates in NAD biosynthesis	 		Atp5o	ATP synthase H ion transporting	â14	part of the mitochondrial ATP synthesis complex	 		Atpi	ATPase inhibitor	â12	prevents ATP hydrolysis during electron flux	 		Ppid	peptidyl prolyl isomerase D (Cyclophilin)	â20	part of mitochondrial transition pore	 		Tim14	translocase complex subunit Tim14	â29	component of the mitochondrial protein import motor	 		Haao	3-hydroxyanthanillate dioxygenase	â12	provides quinolate for NAD synthesis	 	Transcription	Crem	cAMP responsive element modulator	27	PKA activation. Role in glucose and fat metabolism	 		Gtf2a2	general transcription factor IIa 2	12.5	part of the preinitiation transcription complex	 		Gtf2hI	general transcription factor II H, polypeptide 1	3	part of the preinitiation transcription complex	 		MED21	mediator complex subunit 21	11	part of the RNA polymerase II transcription unit	 		MED6	mediator complex subunit 6	9.3	part of the RNA polymerase II transcription unit	 		Rbp1	retinoic acid binding protein	63	RXR formation and PPAR activation	 		DDX52	DEAD box polypeptide 52	18.7	ATP-dependent RNA helicase	 		Ccdc12	Ccdc coiled-coil domain containing 12	14	involved in mRNA splicing	 	</text></passage><passage><infon key="file">pone-0007271-t004.xml</infon><infon key="id">pone-0007271-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>31387</offset><text>Summarizes the interesting categories to emerge from analysis of gene functions (some of which emerged from DAVID and Ingenuity analyses) associated with the list of differentially expressed genes.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>31585</offset><text>Glucose Metabolism</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31604</offset><text> In utero the fetus relies mainly on maternal glucose for its energy supply and only in late gestation develops the capacity for glucose storage and mobilization and for gluconeogenesis in preparation for postnatal life. Glucose and glycogen metabolism appear to have developed inappropriately in the livers of UN animals. Many of the changes in hepatic gene expression we detected are relatively modest and this may reflect alterations in hepatic development. Burns et al. reported changes in the balance of periportal to periarterial hepatocytes which have different metabolic profiles in the offspring of low protein fed dams.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>32234</offset><text>The livers of UN animals show changes in the anomalous expression of RNA for several enzymes involved in glycogenesis, glycogenolysis and glycolysis. There is a 54% increase in the expression of the glycogen synthase gene (GYS2), however, this is counterbalanced by a marked decrease in expression of glucan branching enzyme (GBE1) that is essential for the formation and storage of glycogen. Furthermore, there is a modest decrease in phosphoglucomutase (PGM1) that converts the glucose-1-phosphate resulting from glycogenolysis to glucose-6-phosphate destined for glycolysis. There is also a deficit of triose phosphate isomerase that could result in an inefficient conversion of fructose 1â6 bisphosphate to glyceraldehyde-3 phosphate in the glycolytic process. The reduced expression of triose phosphate isomerase would therefore affect the efficiency of glucose conversion to pyruvate and might indicate an increased accumulation of dihydroxyacetone phosphate. This can readily be reduced to glycerol-3-P that is the backbone for phosphatidates and signaling phospholipids. Overproduction of these could disrupt intracellular function. The efficiency of the citric acid cycle (TCA) would be compromised by the reduction in dehydrogenase E1 (DHTKD1). This enzyme catalyses the conversion of Î±-ketoglutarate to succinyl CoA- a key step in the TCA. Its subsequent conversion to succinate is the only step in glucose catabolism that produces high-energy phosphate (GTP) directly, without the need for oxidative phosphorylation. The GTP can be used for nucleotide-specific metabolic reactions or it can convert ADP to ATP. Production of oxaloacetate further on in the cycle would also be affected. This would slow the rate of formation of citric acid and the entry into the TCA of acetyl-CoA from oxidative decarboxylation of pyruvate. Supplementation of oxaloacetate from metabolism of branched-chain amino acids would also be reduced. This means that most of the oxaloacetate is required as an intermediate for TCA function and less is available for gluconeogenesis. It is interesting to note that there is a reduction in the transcripts of other enzymes involved in the catabolism of amino acids that supply intermediates to the TCA cycle. In the fetus, this impasse may be circumvented to an extent by the presence of the glyoxalate cycle in which acetate can be converted to either glucose or succinate. However, this pathway disappears after birth and hence the inability for gluconeogenesis would be exacerbated postnatally.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>34770</offset><text>Insulin and IGF-1 Signalling</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>34799</offset><text>The insulin and IGF-1 receptors are closely related structurally and share many post-receptor signaling mechanisms. The livers of UN animals show changes in expression of genes whose products are known to attenuate the PI3 kinase signaling pathway that is common to both receptors. Both IGFBP2 and Rbp1 are known to interact with components of the PI3Kinase/Akt signaling pathway IGFBP2 is likely to act by sequestering IGF-1 and preventing binding to its receptor and hence inhibiting downstream activation of PI3K. Rbp1 has been shown to interfere with the heterodimerization of the p85/p110 subunits of Akt. This appears to be a retinoic acid independent effect of Rbp1. An increase in expression of Tribbles homolog 2 (TRB2) has been shown to interfere with the phosphorylation step by PI3K that activates Akt, the effector kinase of this signaling cascade. Conversely increased expression of the protein tyrosine phosphatase (PTPRB) will increase the rate of dephosphorylation of Akt to its inactive form. The concerted effect of these gene expression changes is likely to have the effect of blunting insulin signaling and increasing insulin insensitivity. It is interesting to note that while there is not a significant increase in the levels of circulating insulin, there is a discernable upward trend in UN animals that could indicate the initial stages in the establishment of insulin resistance. One of the major targets of Akt is the insulin-dependent glucose transporter GLUT4 that on activation migrates from the ER to the plasma membrane and facilitates glucose entry into the cell. An additional perturbation of this process in UN animals is suggested by the increased expression of p45/STRAP that has been shown to interfere with GLUT4 trafficking between the ER and the cell membrane. Taken together these findings suggest that the livers of UN animals have altered insulin sensitivity and glucose homeostasis.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>36727</offset><text>A primary function of IGF-1 is to drive postnatal cell proliferation and growth, principally through the MAP kinase signaling pathway. It is only present in low levels in the fetus (where IGF-2 predominates) and increases dramatically in the perinatal period. The liver is the major source of circulating IGF-1. The actions of IGFs are modulated by the presence of a number of binding proteins (IGFBPs), one of which IGFBP2, shows a &gt;2 fold increase in expression in liver of UN animals. IGFBP2 is secreted into the blood and is thought to have a negative effect on IGF-1 activity. In this study, the highly significant reductions in body length and body, spleen, and liver weights lend support to this role. The levels of IGFBP2 have been shown to be high in the early to mid-term fetus and then drop markedly towards term. The persistence of elevated IGFBP2 in UN animals is therefore an abnormality that could have a wide range of effects on postnatal growth and organ development.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>37712</offset><text>Mitochondrial Activity</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>37735</offset><text>The array analysis indicates a number of changes in the expression of genes that could affect the efficiency of electron transport and ATP generation in the mitochondrion in liver from UN animals. Transcripts of NADH dehydrogenase subunits (NDUFC2, NDUFB6 and NDUFA8) of complex I of the electron transport chain are all reduced as is quinolate phosphoribosyltransferase (QPRT) required for the synthesis of NAD, the electron carrier. In addition, the ATP synthase (ATP5o) that generates ATP from the electron gradient is reduced by a similar amount. Changes are also observed in peptidylprolyl isomerase D (PPID) that controls the mitochondrial permeability transition pore and TIM14, a component of the mitochondrial protein import motor. Taken together these findings suggest a degree of mitochondrial dysfunction in the livers of UN animals that could significantly affect the energy balance of the tissue and may be the precursor of later adiposity. Since the liver acts as the initial nutrient sensor, this defect could affect not only its own metabolism but also that of other organs that respond to its systemic signals.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>38864</offset><text>Fat</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>38868</offset><text>In this well-characterized model, it has been shown that undernourishment of dams during pregnancy predisposes offspring to later adiposity and hyperinsulinaemia when fed a normal diet but only at an age later than we have undertaken gene expression analysis. In the present study, even as early as day 110, male offspring of UN dams are showing features of the metabolic syndrome related to increased adiposity and hyperinsulinemia and hyperleptinemia. The absence of any differences in fat expression profiles between control and UN animals at day 55 may suggest that the development of adiposity is secondary to early metabolic perturbations in postnatal life. It is interesting to note that at day 35 UN rats show the onset of a sedentary phenotype (and hence reduced energy expenditure) before the presence of obesity. This may reflect early changes in neurological gene expression modifying behaviour.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>39776</offset><text>The elevated expression of RNA for fatty acid binding protein (FABP7) suggests that in livers from UN animals there is an increase in the intracellular trafficking of fatty acids. This is paralleled by increases in expression of AOX (from qRT-PCR analysis), which catalyses the first step in the peroxisomal degradation of fatty acids, and carnitine acyltransferase (CRAT) that shuttles fatty acids into the mitochondrial matrix. It is interesting to note that the expression of the first enzyme in the biosynthetic pathway of carnitine, trimethyllysine hydroxylase (Tmlhe) is down regulated and this may reflect a homeostatic response to excess fatty acid trafficking. These findings suggest that more energy is derived from Î²-oxidation of fatty acids in these animals. However, this can only be achieved if the NADH from Î²-oxidation regenerates NAD and forms ATP. The observed defects (especially in complex I) indicate a disruption in this process. The provenance of these fatty acids is not clear since there were no significant differences between treatment groups in the circulating levels of either triglycerides or free fatty acids although LDL levels are elevated by maternal undernutrition. Other possible sources of fatty acids could be from increased endogenous synthesis or from turnover of cellular components. There is no evidence from the microarray analysis for an increase in enzymes for the latter; indeed the modest decrease in levels of diacylglycerol acyltransferase (DFAT2) in UN animals would indicate a blunting of triglyceride synthesis in liver.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>41355</offset><text>The increased expression of SREBP cleavage activating protein (SCAP) suggests that there may be higher levels of sterol synthesis taking place in livers of undernourished animals. The formation of a transcriptionally active sterol response element binding protein (SREPB) involves the proteolytic action of SCAP. In support of these observations the levels of circulating LDL cholesterol in the UN group is significantly elevated. Interestingly a 60% increase in 11Î²-HSD2 transcripts was seen in the livers of UN animals accompanied by a similar increase in the expression levels of GR. 11Î²-HSD2 appears in late gestation/postnatal tissues in human fetal tissues. Elevated levels of this enzyme in the livers of UN animals would be a mechanism to moderate the effects of high levels of circulating corticosterone that may arise in response to nutritional deprivation/stress.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>42236</offset><text>Ribosomal Proteins and Protein Turnover</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>42276</offset><text>An intriguing finding of the analysis is an increase (in the range 7â24%) in transcripts in UN animals of 13 of 80 recognized ribosomal proteins (79 of which are represented on the array by multiple oligonucleotides) that occur in the large and small ribosomal subunits. Eight of the proteins are components of the mitochondrial ribosome. Similar increases in expression are also seen in brix (BXDC1), involved in ribosome biogenesis, NPG1, a nucleolar GTPase required for the maturation and nuclear export of pre-ribosomes, and Cebpz, a gene important in the processing of rDNA involved in the 60 s subunit. These findings suggest a greater degree of metabolic flux in ribosomes from UN animals, however it is difficult to understand the significance of these observations given the fact that on the basis of the current annotation only about 16% of the ribosomal proteins show changes in expression levels. It is possible that the increased turnover of ribosomal proteins is contributing to the higher levels of urea observed in the day 55 UN animals.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>43332</offset><text>Effects on Gene Transcription</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>43362</offset><text>It is notable that a group of genes that influence transcription show upregulation to varying extents. Some (such as the Gtf and MED factors) have a general effect on the transcriptional apparatus. The most notable increase is in the Rpb1 gene known to be expressed highly in the liver, particularly in hepatic stellate cells. In liver Rpb1 has an important role in the production of retinoid derivatives that activate the RAR and RXR retinoic acid receptors. RXR can heterodimerise with the PPAR proteins to form active nuclear receptors that target genes involved in fat metabolism and energy homeostasis; for example Crat and AOX are shown to be upregulated in the UN offspring. Thus elevated or abnormal Rbp1 expression may have a major role in establishing the metabolic syndrome phenotype.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>44158</offset><text>Two other genes show significant changes in gene expression that may impact hepatic function. The first is Col14a1 (a member of the collagen gene family) that was originally called undulin. This gene is expressed in hepatic stellate cells that have a role in the formation of the hepatic extra cellular matrix and shows a 20% increase in gene expression. This may be a marker of some underlying pathology as Col14a1 has been associated with the rearrangement of connective tissue occurring in hepatic fibrosis. It is of note that Rbp1 expression changes have also been associated with hepatic fibrosis and thus the gene may be involved in the regulation of Col14a1. The second gene is Adra1b (adrenergic receptor alpha 1b showing a 79% upregulation) that has been associated with carbohydrate metabolism in the liver and disruption of glucose homeostasis when the gene is inactivated. Given that the role of the receptor is to stimulate glycogenolysis and the process of glycogen formation is impaired in UN animals, the significance of increased expression is not clear. This may reflect an irreversible change in response to the intrauterine nutritional state or a postnatal compensatory mechanism to the altered metabolic profile set in utero.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>45405</offset><text>Conclusions</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>45417</offset><text>Studies to date have primarily focused on a candidate gene approach in animals where the classical features of the metabolic syndrome in the programmed phenotype are already evident. There is a relative paucity of data on gene expression, either by candidate or an array-based approach, on key tissues related to the metabolic syndrome in animals at an age preceding development of the metabolic phenotype. The gene expression changes in appropriate pathways in the livers of the male offspring of maternally undernourished dams at day 55 would suggest that these animals may be predisposed to a persistent and perturbed ability to coordinate fat and carbohydrate metabolism with a shift to a use of fatty acids as an energy source. We have also shown that these animals proceed to develop a phenotype similar to that of the metabolic syndrome as early as postnatal day 110. Array analysis of tissues at the day 110 time point was beyond the scope of the present trial. However, although the present study cannot directly correlate the observed gene expression changes at day 55 with the phenotype at day 110, it provides clear evidence of disturbed hepatic function in a number of key genes related to lipid oxidation and mitochondrial function at a pre-phenotypic age. There are parallels with the observations of Koves et al. and Sparks et al. where diet induced obesity in adult life induces oxidative stress associated with increased Î²-oxidation of fat metabolism, impaired switching of carbohydrate substrates, depletion of TCA cycle intermediates, and decreased expression of components of the electron transport chain. They propose that mitochondrial dysfunction may be driving the pre-diabetic insulin resistant state. The observations in our rat model indicate that the liver is irreversibly programmed to respond to a nutritionally restricted environment and that this persists into early adulthood (day 55). At this age, similar changes are not observed in adipose tissue or skeletal muscle, suggesting that the liver can meet the immediate energy requirements of these peripheral tissues and that it manifests metabolic abnormalities in advance of the full metabolic syndrome phenotype. These data have uncovered potential candidate genes and pathways that when perturbed lead to the development of the metabolic syndrome in older animals and therefore provide a focus for more detailed gene-specific studies.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>47843</offset><text>Supporting Information</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>47866</offset><text>Competing Interests: The authors have declared that no competing interests exist.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>47948</offset><text>Funding: This work was funded by the Health Research Council of New Zealand and the National Research Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>48211</offset><text>References</text></passage><passage><infon key="fpage">1733</infon><infon key="lpage">1736</infon><infon key="name_0">surname:Gluckman;given-names:PD</infon><infon key="name_1">surname:Hanson;given-names:MA</infon><infon key="pub-id_pmid">15375258</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">305</infon><infon key="year">2004</infon><offset>48222</offset><text>Living with the past: evolution, development, and patterns of disease.</text></passage><passage><infon key="fpage">928</infon><infon key="lpage">934</infon><infon key="name_0">surname:Bateson;given-names:P</infon><infon key="pub-id_pmid">11689495</infon><infon key="section_type">REF</infon><infon key="source">Int J Epidemiol</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2001</infon><offset>48293</offset><text>Fetal experience and good adult design.</text></passage><passage><infon key="fpage">671</infon><infon key="lpage">677</infon><infon key="name_0">surname:Gluckman;given-names:PD</infon><infon key="name_1">surname:Hanson;given-names:MA</infon><infon key="name_2">surname:Spencer;given-names:HG</infon><infon key="name_3">surname:Bateson;given-names:P</infon><infon key="pub-id_pmid">15870029</infon><infon key="section_type">REF</infon><infon key="source">Proc Biol Sci</infon><infon key="type">ref</infon><infon key="volume">272</infon><infon key="year">2005</infon><offset>48333</offset><text>Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies.</text></passage><passage><infon key="fpage">419</infon><infon key="lpage">421</infon><infon key="name_0">surname:Bateson;given-names:P</infon><infon key="name_1">surname:Barker;given-names:D</infon><infon key="name_2">surname:Clutton-Brock;given-names:T</infon><infon key="name_3">surname:Deb;given-names:D</infon><infon key="name_4">surname:D'Udine;given-names:B</infon><infon key="pub-id_pmid">15269759</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">430</infon><infon key="year">2004</infon><offset>48488</offset><text>Developmental plasticity and human health.</text></passage><passage><infon key="fpage">571</infon><infon key="lpage">633</infon><infon key="name_0">surname:McMillen;given-names:IC</infon><infon key="name_1">surname:Robinson;given-names:JS</infon><infon key="pub-id_pmid">15788706</infon><infon key="section_type">REF</infon><infon key="source">Physiol Rev</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">2005</infon><offset>48531</offset><text>Developmental origins of the metabolic syndrome: prediction, plasticity, and programming.</text></passage><passage><infon key="fpage">5</infon><infon key="lpage">20</infon><infon key="name_0">surname:Hales;given-names:CN</infon><infon key="name_1">surname:Barker;given-names:DJ</infon><infon key="pub-id_pmid">11809615</infon><infon key="section_type">REF</infon><infon key="source">Br Med Bull</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">2001</infon><offset>48621</offset><text>The thrifty phenotype hypothesis.</text></passage><passage><infon key="fpage">127</infon><infon key="lpage">139</infon><infon key="name_0">surname:Gluckman;given-names:PD</infon><infon key="name_1">surname:Hanson;given-names:MA</infon><infon key="name_2">surname:Morton;given-names:SM</infon><infon key="name_3">surname:Pinal;given-names:CS</infon><infon key="pub-id_pmid">15564779</infon><infon key="section_type">REF</infon><infon key="source">Biol Neonate</infon><infon key="type">ref</infon><infon key="volume">87</infon><infon key="year">2005</infon><offset>48655</offset><text>Life-long echoesâa critical analysis of the developmental origins of adult disease model.</text></passage><passage><infon key="fpage">31</infon><infon key="lpage">35</infon><infon key="name_0">surname:Barker;given-names:DJ</infon><infon key="pub-id_pmid">11315417</infon><infon key="section_type">REF</infon><infon key="source">Med Health Care Philos</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2001</infon><offset>48747</offset><text>A new model for the origins of chronic disease.</text></passage><passage><infon key="fpage">130</infon><infon key="lpage">141</infon><infon key="name_0">surname:Gluckman;given-names:PD</infon><infon key="name_1">surname:Hanson;given-names:MA</infon><infon key="name_2">surname:Pinal;given-names:C</infon><infon key="pub-id_pmid">16881892</infon><infon key="section_type">REF</infon><infon key="source">Matern Child Nutr</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2005</infon><offset>48795</offset><text>The developmental origins of adult disease.</text></passage><passage><infon key="fpage">E83</infon><infon key="lpage">87</infon><infon key="name_0">surname:Vickers;given-names:MH</infon><infon key="name_1">surname:Breier;given-names:BH</infon><infon key="name_2">surname:Cutfield;given-names:WS</infon><infon key="name_3">surname:Hofman;given-names:PL</infon><infon key="name_4">surname:Gluckman;given-names:PD</infon><infon key="pub-id_pmid">10893326</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2000</infon><offset>48839</offset><text>Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition.</text></passage><passage><infon key="fpage">1382</infon><infon key="lpage">1386</infon><infon key="name_0">surname:Lillycrop;given-names:KA</infon><infon key="name_1">surname:Phillips;given-names:ES</infon><infon key="name_2">surname:Jackson;given-names:AA</infon><infon key="name_3">surname:Hanson;given-names:MA</infon><infon key="name_4">surname:Burdge;given-names:GC</infon><infon key="pub-id_pmid">15930441</infon><infon key="section_type">REF</infon><infon key="source">J Nutr</infon><infon key="type">ref</infon><infon key="volume">135</infon><infon key="year">2005</infon><offset>48950</offset><text>Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring.</text></passage><passage><infon key="fpage">6</infon><infon key="lpage">21</infon><infon key="name_0">surname:Bird;given-names:A</infon><infon key="pub-id_pmid">11782440</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="year">2002</infon><offset>49112</offset><text>DNA methylation patterns and epigenetic memory.</text></passage><passage><infon key="fpage">2841</infon><infon key="lpage">2853</infon><infon key="name_0">surname:Bertram;given-names:C</infon><infon key="name_1">surname:Trowern;given-names:AR</infon><infon key="name_2">surname:Copin;given-names:N</infon><infon key="name_3">surname:Jackson;given-names:AA</infon><infon key="name_4">surname:Whorwood;given-names:CB</infon><infon key="pub-id_pmid">11416003</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">142</infon><infon key="year">2001</infon><offset>49160</offset><text>The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero.</text></passage><passage><infon key="fpage">219</infon><infon key="lpage">232</infon><infon key="name_0">surname:Drake;given-names:AJ</infon><infon key="name_1">surname:Tang;given-names:JI</infon><infon key="name_2">surname:Nyirenda;given-names:MJ</infon><infon key="pub-id_pmid">17663659</infon><infon key="section_type">REF</infon><infon key="source">Clin Sci (Lond)</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="year">2007</infon><offset>49386</offset><text>Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease.</text></passage><passage><infon key="fpage">231</infon><infon key="lpage">242</infon><infon key="name_0">surname:Woodall;given-names:SM</infon><infon key="name_1">surname:Breier;given-names:BH</infon><infon key="name_2">surname:Johnston;given-names:BM</infon><infon key="name_3">surname:Gluckman;given-names:PD</infon><infon key="pub-id_pmid">8869590</infon><infon key="section_type">REF</infon><infon key="source">J Endocrinol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">1996</infon><offset>49484</offset><text>A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth.</text></passage><passage><infon key="fpage">1906</infon><infon key="lpage">1913</infon><infon key="name_0">surname:Vickers;given-names:MH</infon><infon key="name_1">surname:Gluckman;given-names:PD</infon><infon key="name_2">surname:Coveny;given-names:AH</infon><infon key="name_3">surname:Hofman;given-names:PL</infon><infon key="name_4">surname:Cutfield;given-names:WS</infon><infon key="pub-id_pmid">18187552</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2008</infon><offset>49637</offset><text>The effect of neonatal leptin treatment on postnatal weight gain in male rats is dependent on maternal nutritional status during pregnancy.</text></passage><passage><infon key="fpage">Article3</infon><infon key="name_0">surname:Smyth;given-names:GK</infon><infon key="pub-id_pmid">16646809</infon><infon key="section_type">REF</infon><infon key="source">Stat Appl Genet Mol Biol</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>49777</offset><text>Linear models and empirical bayes methods for assessing differential expression in microarray experiments.</text></passage><passage><infon key="fpage">1547</infon><infon key="lpage">1548</infon><infon key="name_0">surname:Du;given-names:P</infon><infon key="name_1">surname:Kibbe;given-names:WA</infon><infon key="name_2">surname:Lin;given-names:SM</infon><infon key="pub-id_pmid">18467348</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2008</infon><offset>49884</offset><text>lumi: a pipeline for processing Illumina microarray.</text></passage><passage><infon key="fpage">e11</infon><infon key="name_0">surname:Lin;given-names:SM</infon><infon key="name_1">surname:Du;given-names:P</infon><infon key="name_2">surname:Huber;given-names:W</infon><infon key="name_3">surname:Kibbe;given-names:WA</infon><infon key="pub-id_pmid">18178591</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2008</infon><offset>49937</offset><text>Model-based variance-stabilizing transformation for Illumina microarray data.</text></passage><passage><infon key="fpage">P3</infon><infon key="name_0">surname:Dennis;given-names:G;suffix:Jr</infon><infon key="name_1">surname:Sherman;given-names:BT</infon><infon key="name_2">surname:Hosack;given-names:DA</infon><infon key="name_3">surname:Yang;given-names:J</infon><infon key="name_4">surname:Gao;given-names:W</infon><infon key="pub-id_pmid">12734009</infon><infon key="section_type">REF</infon><infon key="source">Genome Biol</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2003</infon><offset>50015</offset><text>DAVID: Database for Annotation, Visualization, and Integrated Discovery.</text></passage><passage><infon key="fpage">12796</infon><infon key="lpage">12800</infon><infon key="name_0">surname:Gluckman;given-names:PD</infon><infon key="name_1">surname:Lillycrop;given-names:KA</infon><infon key="name_2">surname:Vickers;given-names:MH</infon><infon key="name_3">surname:Pleasants;given-names:AB</infon><infon key="name_4">surname:Phillips;given-names:ES</infon><infon key="pub-id_pmid">17646663</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2007</infon><offset>50088</offset><text>Metabolic plasticity during mammalian development is directionally dependent on early nutritional status.</text></passage><passage><infon key="fpage">10173</infon><infon key="lpage">10176</infon><infon key="name_0">surname:Granner;given-names:D</infon><infon key="name_1">surname:Pilkis;given-names:S</infon><infon key="pub-id_pmid">2191945</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">265</infon><infon key="year">1990</infon><offset>50194</offset><text>The genes of hepatic glucose metabolism.</text></passage><passage><infon key="fpage">459</infon><infon key="lpage">467</infon><infon key="name_0">surname:Bertram;given-names:CE</infon><infon key="name_1">surname:Hanson;given-names:MA</infon><infon key="pub-id_pmid">12361463</infon><infon key="section_type">REF</infon><infon key="source">Reproduction</infon><infon key="type">ref</infon><infon key="volume">124</infon><infon key="year">2002</infon><offset>50235</offset><text>Prenatal programming of postnatal endocrine responses by glucocorticoids.</text></passage><passage><infon key="fpage">4211</infon><infon key="lpage">4216</infon><infon key="name_0">surname:Vickers;given-names:MH</infon><infon key="name_1">surname:Gluckman;given-names:PD</infon><infon key="name_2">surname:Coveny;given-names:AH</infon><infon key="name_3">surname:Hofman;given-names:PL</infon><infon key="name_4">surname:Cutfield;given-names:WS</infon><infon key="pub-id_pmid">16020474</infon><infon key="section_type">REF</infon><infon key="source">Endocrinology</infon><infon key="type">ref</infon><infon key="volume">146</infon><infon key="year">2005</infon><offset>50309</offset><text>Neonatal leptin treatment reverses developmental programming.</text></passage><passage><infon key="fpage">235</infon><infon key="lpage">241</infon><infon key="name_0">surname:Ozanne;given-names:SE</infon><infon key="name_1">surname:Olsen;given-names:GS</infon><infon key="name_2">surname:Hansen;given-names:LL</infon><infon key="name_3">surname:Tingey;given-names:KJ</infon><infon key="name_4">surname:Nave;given-names:BT</infon><infon key="pub-id_pmid">12740011</infon><infon key="section_type">REF</infon><infon key="source">J Endocrinol</infon><infon key="type">ref</infon><infon key="volume">177</infon><infon key="year">2003</infon><offset>50371</offset><text>Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle.</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">14</infon><infon key="name_0">surname:Ozanne;given-names:SE</infon><infon key="name_1">surname:Hales;given-names:CN</infon><infon key="section_type">REF</infon><infon key="source">Expert Rev Mol Med</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2002</infon><offset>50489</offset><text>Pre- and early postnatal nongenetic determinants of type 2 diabetes.</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">56</infon><infon key="name_0">surname:Koves;given-names:TR</infon><infon key="name_1">surname:Ussher;given-names:JR</infon><infon key="name_2">surname:Noland;given-names:RC</infon><infon key="name_3">surname:Slentz;given-names:D</infon><infon key="name_4">surname:Mosedale;given-names:M</infon><infon key="pub-id_pmid">18177724</infon><infon key="section_type">REF</infon><infon key="source">Cell Metab</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2008</infon><offset>50558</offset><text>Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.</text></passage><passage><infon key="fpage">1768</infon><infon key="lpage">1774</infon><infon key="name_0">surname:Burns;given-names:SP</infon><infon key="name_1">surname:Desai;given-names:M</infon><infon key="name_2">surname:Cohen;given-names:RD</infon><infon key="name_3">surname:Hales;given-names:CN</infon><infon key="name_4">surname:Iles;given-names:RA</infon><infon key="pub-id_pmid">9312176</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">1997</infon><offset>50667</offset><text>Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation.</text></passage><passage><infon key="fpage">346</infon><infon key="lpage">351; discussion 351â342</infon><infon key="name_0">surname:Keller;given-names:SR</infon><infon key="name_1">surname:Lamphere;given-names:L</infon><infon key="name_2">surname:Lavan;given-names:BE</infon><infon key="name_3">surname:Kuhne;given-names:MR</infon><infon key="name_4">surname:Lienhard;given-names:GE</infon><infon key="pub-id_pmid">8398112</infon><infon key="section_type">REF</infon><infon key="source">Mol Reprod Dev</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">1993</infon><offset>50828</offset><text>Insulin and IGF-I signaling through the insulin receptor substrate 1.</text></passage><passage><infon key="fpage">1598</infon><infon key="lpage">1606</infon><infon key="name_0">surname:Farias;given-names:EF</infon><infon key="name_1">surname:Marzan;given-names:C</infon><infon key="name_2">surname:Mira-y-Lopez;given-names:R</infon><infon key="pub-id_pmid">15608670</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2005</infon><offset>50898</offset><text>Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85âp110 heterodimerization.</text></passage><passage><infon key="fpage">2993</infon><infon key="lpage">2999</infon><infon key="name_0">surname:Ozanne;given-names:SE</infon><infon key="name_1">surname:Jensen;given-names:CB</infon><infon key="name_2">surname:Tingey;given-names:KJ</infon><infon key="name_3">surname:Martin-Gronert;given-names:MS</infon><infon key="name_4">surname:Grunnet;given-names:L</infon><infon key="pub-id_pmid">17063325</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2006</infon><offset>51060</offset><text>Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight: potential link to increased risk of diabetes?</text></passage><passage><infon key="fpage">R271</infon><infon key="lpage">273</infon><infon key="name_0">surname:Vickers;given-names:MH</infon><infon key="name_1">surname:Breier;given-names:BH</infon><infon key="name_2">surname:McCarthy;given-names:D</infon><infon key="name_3">surname:Gluckman;given-names:PD</infon><infon key="pub-id_pmid">12794001</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol Regul Integr Comp Physiol</infon><infon key="type">ref</infon><infon key="volume">285</infon><infon key="year">2003</infon><offset>51224</offset><text>Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition.</text></passage><passage><infon key="fpage">331</infon><infon key="lpage">340</infon><infon key="name_0">surname:Brown;given-names:MS</infon><infon key="name_1">surname:Goldstein;given-names:JL</infon><infon key="pub-id_pmid">9150132</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="year">1997</infon><offset>51360</offset><text>The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.</text></passage><passage><infon key="fpage">1529</infon><infon key="lpage">1532</infon><infon key="name_0">surname:Stewart;given-names:PM</infon><infon key="name_1">surname:Murry;given-names:BA</infon><infon key="name_2">surname:Mason;given-names:JI</infon><infon key="pub-id_pmid">8200959</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">1994</infon><offset>51473</offset><text>Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.</text></passage><passage><infon key="fpage">499</infon><infon key="lpage">509</infon><infon key="name_0">surname:Milkereit;given-names:P</infon><infon key="name_1">surname:Gadal;given-names:O</infon><infon key="name_2">surname:Podtelejnikov;given-names:A</infon><infon key="name_3">surname:Trumtel;given-names:S</infon><infon key="name_4">surname:Gas;given-names:N</infon><infon key="pub-id_pmid">11371346</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">2001</infon><offset>51541</offset><text>Maturation and intranuclear transport of pre-ribosomes requires Noc proteins.</text></passage><passage><infon key="fpage">619</infon><infon key="lpage">628</infon><infon key="name_0">surname:Uchio;given-names:K</infon><infon key="name_1">surname:Tuchweber;given-names:B</infon><infon key="name_2">surname:Manabe;given-names:N</infon><infon key="name_3">surname:Gabbiani;given-names:G</infon><infon key="name_4">surname:Rosenbaum;given-names:J</infon><infon key="pub-id_pmid">12004002</infon><infon key="section_type">REF</infon><infon key="source">Lab Invest</infon><infon key="type">ref</infon><infon key="volume">82</infon><infon key="year">2002</infon><offset>51619</offset><text>Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts.</text></passage><passage><infon key="fpage">774</infon><infon key="lpage">780</infon><infon key="name_0">surname:Lepreux;given-names:S</infon><infon key="name_1">surname:Bioulac-Sage;given-names:P</infon><infon key="name_2">surname:Gabbiani;given-names:G</infon><infon key="name_3">surname:Sapin;given-names:V</infon><infon key="name_4">surname:Housset;given-names:C</infon><infon key="pub-id_pmid">15094224</infon><infon key="section_type">REF</infon><infon key="source">J Hepatol</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2004</infon><offset>51794</offset><text>Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations.</text></passage><passage><infon key="fpage">32</infon><infon key="lpage">38</infon><infon key="name_0">surname:Ziouzenkova;given-names:O</infon><infon key="name_1">surname:Plutzky;given-names:J</infon><infon key="pub-id_pmid">18068127</infon><infon key="section_type">REF</infon><infon key="source">FEBS Lett</infon><infon key="type">ref</infon><infon key="volume">582</infon><infon key="year">2008</infon><offset>51981</offset><text>Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.</text></passage><passage><infon key="fpage">908</infon><infon key="lpage">916</infon><infon key="name_0">surname:Milani;given-names:S</infon><infon key="name_1">surname:Grappone;given-names:C</infon><infon key="name_2">surname:Pellegrini;given-names:G</infon><infon key="name_3">surname:Schuppan;given-names:D</infon><infon key="name_4">surname:Herbst;given-names:H</infon><infon key="pub-id_pmid">7523266</infon><infon key="section_type">REF</infon><infon key="source">Hepatology</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1994</infon><offset>52099</offset><text>Undulin RNA and protein expression in normal and fibrotic human liver.</text></passage><passage><infon key="fpage">595</infon><infon key="lpage">601</infon><infon key="name_0">surname:Gerecke;given-names:DR</infon><infon key="name_1">surname:Meng;given-names:X</infon><infon key="name_2">surname:Liu;given-names:B</infon><infon key="name_3">surname:Birk;given-names:DE</infon><infon key="pub-id_pmid">15065570</infon><infon key="section_type">REF</infon><infon key="source">Matrix Biol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2004</infon><offset>52170</offset><text>Complete primary structure and genomic organization of the mouse Col14a1 gene.</text></passage><passage><infon key="fpage">III</infon><infon key="lpage">XIII, 1â151</infon><infon key="name_0">surname:Kmiec;given-names:Z</infon><infon key="pub-id_pmid">11729749</infon><infon key="section_type">REF</infon><infon key="source">Adv Anat Embryol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">161</infon><infon key="year">2001</infon><offset>52249</offset><text>Cooperation of liver cells in health and disease.</text></passage><passage><infon key="fpage">1185</infon><infon key="lpage">1191</infon><infon key="name_0">surname:Kunos;given-names:G</infon><infon key="name_1">surname:Ishac;given-names:EJ</infon><infon key="pub-id_pmid">3036161</infon><infon key="section_type">REF</infon><infon key="source">Biochem Pharmacol</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">1987</infon><offset>52299</offset><text>Mechanism of inverse regulation of alpha 1- and beta-adrenergic receptors.</text></passage><passage><infon key="fpage">1108</infon><infon key="lpage">1115</infon><infon key="name_0">surname:Burcelin;given-names:R</infon><infon key="name_1">surname:Uldry;given-names:M</infon><infon key="name_2">surname:Foretz;given-names:M</infon><infon key="name_3">surname:Perrin;given-names:C</infon><infon key="name_4">surname:Dacosta;given-names:A</infon><infon key="pub-id_pmid">14581480</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2004</infon><offset>52374</offset><text>Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype.</text></passage><passage><infon key="fpage">C1664</infon><infon key="lpage">1672</infon><infon key="name_0">surname:Begin-Heick;given-names:N</infon><infon key="pub-id_pmid">8023896</infon><infon key="section_type">REF</infon><infon key="source">Am J Physiol</infon><infon key="type">ref</infon><infon key="volume">266</infon><infon key="year">1994</infon><offset>52460</offset><text>Liver beta-adrenergic receptors, G proteins, and adenylyl cyclase activity in obesity-diabetes syndromes.</text></passage><passage><infon key="fpage">1926</infon><infon key="lpage">1933</infon><infon key="name_0">surname:Sparks;given-names:LM</infon><infon key="name_1">surname:Xie;given-names:H</infon><infon key="name_2">surname:Koza;given-names:RA</infon><infon key="name_3">surname:Mynatt;given-names:R</infon><infon key="name_4">surname:Hulver;given-names:MW</infon><infon key="pub-id_pmid">15983191</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2005</infon><offset>52566</offset><text>A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle.</text></passage><passage><infon key="fpage">1574</infon><infon key="lpage">1577</infon><infon key="name_0">surname:Du;given-names:K</infon><infon key="name_1">surname:Herzig;given-names:S</infon><infon key="name_2">surname:Kulkarni;given-names:RN</infon><infon key="name_3">surname:Montminy;given-names:M</infon><infon key="pub-id_pmid">12791994</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="year">2003</infon><offset>52688</offset><text>TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.</text></passage><passage><infon key="fpage">15038</infon><infon key="lpage">15046</infon><infon key="name_0">surname:Haj;given-names:FG</infon><infon key="name_1">surname:Zabolotny;given-names:JM</infon><infon key="name_2">surname:Kim;given-names:YB</infon><infon key="name_3">surname:Kahn;given-names:BB</infon><infon key="name_4">surname:Neel;given-names:BG</infon><infon key="pub-id_pmid">15699041</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">280</infon><infon key="year">2005</infon><offset>52767</offset><text>Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1Bâ/âmice.</text></passage><passage><infon key="fpage">1179</infon><infon key="lpage">1185</infon><infon key="name_0">surname:Lisinski;given-names:I</infon><infon key="name_1">surname:Matsumoto;given-names:H</infon><infon key="name_2">surname:Yver;given-names:DR</infon><infon key="name_3">surname:Schurmann;given-names:A</infon><infon key="name_4">surname:Cushman;given-names:SW</infon><infon key="pub-id_pmid">16647043</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">344</infon><infon key="year">2006</infon><offset>52884</offset><text>Identification and characterization of p49/STRAP as a novel GLUT4-binding protein.</text></passage><passage><infon key="fpage">910</infon><infon key="lpage">914</infon><infon key="name_0">surname:Iwahashi;given-names:H</infon><infon key="name_1">surname:Yamagata;given-names:K</infon><infon key="name_2">surname:Yoshiuchi;given-names:I</infon><infon key="name_3">surname:Terasaki;given-names:J</infon><infon key="name_4">surname:Yang;given-names:Q</infon><infon key="pub-id_pmid">11916906</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2002</infon><offset>52967</offset><text>Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alpha.</text></passage><passage><infon key="fpage">1206</infon><infon key="lpage">1216</infon><infon key="name_0">surname:Matsuda;given-names:M</infon><infon key="name_1">surname:Korn;given-names:BS</infon><infon key="name_2">surname:Hammer;given-names:RE</infon><infon key="name_3">surname:Moon;given-names:YA</infon><infon key="name_4">surname:Komuro;given-names:R</infon><infon key="pub-id_pmid">11358865</infon><infon key="section_type">REF</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2001</infon><offset>53082</offset><text>SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.</text></passage><passage><infon key="fpage">285</infon><infon key="lpage">294</infon><infon key="name_0">surname:Wheatcroft;given-names:SB</infon><infon key="name_1">surname:Kearney;given-names:MT</infon><infon key="name_2">surname:Shah;given-names:AM</infon><infon key="name_3">surname:Ezzat;given-names:VA</infon><infon key="name_4">surname:Miell;given-names:JR</infon><infon key="pub-id_pmid">17259371</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2007</infon><offset>53232</offset><text>IGF-binding protein-2 protects against the development of obesity and insulin resistance.</text></passage><passage><infon key="fpage">163</infon><infon key="lpage">174</infon><infon key="name_0">surname:Lam;given-names:NT</infon><infon key="name_1">surname:Covey;given-names:SD</infon><infon key="name_2">surname:Lewis;given-names:JT</infon><infon key="name_3">surname:Oosman;given-names:S</infon><infon key="name_4">surname:Webber;given-names:T</infon><infon key="pub-id_pmid">16461936</infon><infon key="section_type">REF</infon><infon key="source">J Mol Endocrinol</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2006</infon><offset>53322</offset><text>Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver.</text></passage><passage><infon key="fpage">4759</infon><infon key="lpage">4765</infon><infon key="name_0">surname:Gummesson;given-names:A</infon><infon key="name_1">surname:Jernas;given-names:M</infon><infon key="name_2">surname:Svensson;given-names:PA</infon><infon key="name_3">surname:Larsson;given-names:I</infon><infon key="name_4">surname:Glad;given-names:CA</infon><infon key="pub-id_pmid">17895319</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">2007</infon><offset>53411</offset><text>Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies.</text></passage><passage><infon key="fpage">3032</infon><infon key="lpage">3034</infon><infon key="name_0">surname:Dahlman;given-names:I</infon><infon key="name_1">surname:Kaaman;given-names:M</infon><infon key="name_2">surname:Jiao;given-names:H</infon><infon key="name_3">surname:Kere;given-names:J</infon><infon key="name_4">surname:Laakso;given-names:M</infon><infon key="pub-id_pmid">16186410</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2005</infon><offset>53570</offset><text>The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects.</text></passage><passage><infon key="fpage">49</infon><infon key="lpage">56</infon><infon key="name_0">surname:Zhou;given-names:Z</infon><infon key="name_1">surname:Yon Toh;given-names:S</infon><infon key="name_2">surname:Chen;given-names:Z</infon><infon key="name_3">surname:Guo;given-names:K</infon><infon key="name_4">surname:Ng;given-names:CP</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2003</infon><offset>53652</offset><text>Cidea-deficient mice have lean phenotype and are resistant to obesity.</text></passage><passage><infon key="fpage">383</infon><infon key="lpage">393</infon><infon key="name_0">surname:Bibikova;given-names:M</infon><infon key="name_1">surname:Lin;given-names:Z</infon><infon key="name_2">surname:Zhou;given-names:L</infon><infon key="name_3">surname:Chudin;given-names:E</infon><infon key="name_4">surname:Garcia;given-names:EW</infon><infon key="pub-id_pmid">16449502</infon><infon key="section_type">REF</infon><infon key="source">Genome Res</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2006</infon><offset>53723</offset><text>High-throughput DNA methylation profiling using universal bead arrays.</text></passage><passage><infon key="fpage">875</infon><infon key="lpage">885</infon><infon key="name_0">surname:Stanhill;given-names:A</infon><infon key="name_1">surname:Haynes;given-names:CM</infon><infon key="name_2">surname:Zhang;given-names:Y</infon><infon key="name_3">surname:Min;given-names:G</infon><infon key="name_4">surname:Steele;given-names:MC</infon><infon key="pub-id_pmid">16973439</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2006</infon><offset>53794</offset><text>An arsenite-inducible 19S regulatory particle-associated protein adapts proteasomes to proteotoxicity.</text></passage><passage><infon key="fpage">867</infon><infon key="lpage">874</infon><infon key="name_0">surname:Min;given-names:KW</infon><infon key="name_1">surname:Kwon;given-names:MJ</infon><infon key="name_2">surname:Park;given-names:HS</infon><infon key="name_3">surname:Park;given-names:Y</infon><infon key="name_4">surname:Yoon;given-names:SK</infon><infon key="pub-id_pmid">16036220</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">334</infon><infon key="year">2005</infon><offset>53897</offset><text>CAND1 enhances deneddylation of CUL1 by COP9 signalosome.</text></passage><passage><infon key="fpage">1257</infon><infon key="lpage">1261</infon><infon key="name_0">surname:Kurz;given-names:T</infon><infon key="name_1">surname:Ozlu;given-names:N</infon><infon key="name_2">surname:Rudolf;given-names:F</infon><infon key="name_3">surname:O'Rourke;given-names:SM</infon><infon key="name_4">surname:Luke;given-names:B</infon><infon key="pub-id_pmid">15988528</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">435</infon><infon key="year">2005</infon><offset>53955</offset><text>The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae.</text></passage><passage><infon key="fpage">345</infon><infon key="lpage">347</infon><infon key="name_0">surname:Eisenhaber;given-names:F</infon><infon key="name_1">surname:Wechselberger;given-names:C</infon><infon key="name_2">surname:Kreil;given-names:G</infon><infon key="pub-id_pmid">11406393</infon><infon key="section_type">REF</infon><infon key="source">Trends Biochem Sci</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2001</infon><offset>54057</offset><text>The Brix domain protein family â a key to the ribosomal biogenesis pathway?</text></passage><passage><infon key="fpage">1281</infon><infon key="lpage">1290</infon><infon key="name_0">surname:Reiss;given-names:U</infon><infon key="name_1">surname:Oskouian;given-names:B</infon><infon key="name_2">surname:Zhou;given-names:J</infon><infon key="name_3">surname:Gupta;given-names:V</infon><infon key="name_4">surname:Sooriyakumaran;given-names:P</infon><infon key="pub-id_pmid">14570870</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="year">2004</infon><offset>54135</offset><text>Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis.</text></passage></document></collection>
